Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Retatrutide is a triple agonist (GLP-1 + GIP + glucagon), tirzepatide is a dual agonist (GLP-1 + GIP), and semaglutide is a single agonist (GLP-1)
But: GLP-1s help you maintain the calorie deficit required for overall fat loss, which includes visceral abdominal fat (the dangerous kind around your organs) and subcutaneous belly fat (the pinchable kind under your skin)
Each 550 mg capsule is designed to be taken just twice a day, and studies show berberine can outperform Metformin when it comes to improving insulin resistance and balancing hormones
Semaglutide with Vitamin B12 or L-Carnitine Vitamin B12 (cyanocobalamin) is a methylation cofactor that supports energy production and red blood cell health
Zepbound makes sense if you: Want to start treatment now under a licensed prescriber Value a drug with completed Phase 3 data and FDA approval Have insurance coverage or can use the self-pay vial program Prefer a known, regulated safety profile Retatrutide may interest you if you: Are tracking the most aggressive weight-loss results in development Did not reach your goal on tirzepatide and want to know what comes next Are willing to wait for FDA approval rather than buy unregulated material Want to discuss clinical trial enrollment with your doctor For people already on Zepbound who are curious about a future switch, the practical considerations are laid out in switching from tirzepatide to retatrutide
Rubino F, Nathan DM, Eckel RH et al (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations
